Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/93369
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChew, M.S.X.-
dc.contributor.authorDhillon, R.-
dc.contributor.authorTibrewal, P.-
dc.contributor.authorNarang, B.-
dc.date.issued2013-
dc.identifier.citationAustralian and New Zealand Journal of Psychiatry, 2013; 47(12):1214-1215-
dc.identifier.issn0004-8674-
dc.identifier.issn1440-1614-
dc.identifier.urihttp://hdl.handle.net/2440/93369-
dc.descriptionLetter to the Editor-
dc.description.statementofresponsibilityMajella Su-Xian Chew, Rohan Dhillon, Prashant Tibrewal, and Birinder Narang-
dc.language.isoen-
dc.publisherSAGE Publications-
dc.rightsCopyright status unknown-
dc.source.urihttp://dx.doi.org/10.1177/0004867413500355-
dc.subjectBenzodiazepines-
dc.titleOlanzapine long-acting injection: when and for how long is oral supplementation required?-
dc.typeJournal article-
dc.identifier.doi10.1177/0004867413500355-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest 2
Psychiatry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.